List of Contents

Sinus Dilation Devices Market Size, Share, and Trends 2024 to 2033

Sinus Dilation Devices Market (By Product: Balloon Sinus Dilation Devices, Endoscopes, Sinus Stents/Implants, Functional Endoscopic Sinus Surgery (FESS) Instruments Set, Others; By Type: Sinuscopes, Rhinoscopes; By Procedure: Standalone, Hybrid; By Patient: Adult, Pediatric; By End-use: Hospitals, Ambulatory Surgical Centers, Ent Clinics/in Office) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033

  • Last Updated : June 2024
  • Report Code : 4411
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Sinus Dilation Devices Market 

5.1. COVID-19 Landscape: Sinus Dilation Devices Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Sinus Dilation Devices Market, By Product

8.1. Sinus Dilation Devices Market Revenue and Volume, by Product, 2024-2033

8.1.1. Balloon Sinus Dilation Devices

8.1.1.1. Market Revenue and Volume Forecast (2021-2033)

8.1.2. Endoscopes

8.1.2.1. Market Revenue and Volume Forecast (2021-2033)

8.1.3. Sinus Stents/Implants

8.1.3.1. Market Revenue and Volume Forecast (2021-2033)

8.1.4. Functional Endoscopic Sinus Surgery (FESS) Instruments Set

8.1.4.1. Market Revenue and Volume Forecast (2021-2033)

8.1.5. Others

8.1.5.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 9. Global Sinus Dilation Devices Market, By Type

9.1. Sinus Dilation Devices Market Revenue and Volume, by Type, 2024-2033

9.1.1. Sinuscopes

9.1.1.1. Market Revenue and Volume Forecast (2021-2033)

9.1.2. Rhinoscopes

9.1.2.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 10. Global Sinus Dilation Devices Market, By Procedure 

10.1. Sinus Dilation Devices Market Revenue and Volume, by Procedure, 2024-2033

10.1.1. Standalone

10.1.1.1. Market Revenue and Volume Forecast (2021-2033)

10.1.2. Hybrid

10.1.2.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 11. Global Sinus Dilation Devices Market, By Patient

11.1. Sinus Dilation Devices Market Revenue and Volume, by Patient, 2024-2033

11.1.1. Adult

11.1.1.1. Market Revenue and Volume Forecast (2021-2033)

11.1.2. Pediatric

11.1.2.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 12. Global Sinus Dilation Devices Market, By End-use

12.1. Sinus Dilation Devices Market Revenue and Volume, by End-use, 2024-2033

12.1.1. Hospitals

12.1.1.1. Market Revenue and Volume Forecast (2021-2033)

12.1.2. Ambulatory Surgical Centers

12.1.2.1. Market Revenue and Volume Forecast (2021-2033)

12.1.3. Foundries

12.1.3.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 13. Global Sinus Dilation Devices Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.1.2. Market Revenue and Volume Forecast, by Type (2021-2033)

13.1.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)

13.1.4. Market Revenue and Volume Forecast, by Patient (2021-2033)

13.1.5. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.1.6. U.S.

13.1.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.1.6.2. Market Revenue and Volume Forecast, by Type (2021-2033)

13.1.6.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)

13.1.6.4. Market Revenue and Volume Forecast, by Patient (2021-2033)

13.1.6.5. Market Revenue and Volume Forecast, by End-use (2021-2033) 

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.1.7.2. Market Revenue and Volume Forecast, by Type (2021-2033)

13.1.7.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)

13.1.7.4. Market Revenue and Volume Forecast, by Patient (2021-2033)

13.1.7.5. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.2. Europe

13.2.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.2.2. Market Revenue and Volume Forecast, by Type (2021-2033)

13.2.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)

13.2.4. Market Revenue and Volume Forecast, by Patient (2021-2033) 

13.2.5. Market Revenue and Volume Forecast, by End-use (2021-2033) 

13.2.6. UK

13.2.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.2.6.2. Market Revenue and Volume Forecast, by Type (2021-2033)

13.2.6.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)

13.2.7. Market Revenue and Volume Forecast, by Patient (2021-2033) 

13.2.8. Market Revenue and Volume Forecast, by End-use (2021-2033) 

13.2.9. Germany

13.2.9.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.2.9.2. Market Revenue and Volume Forecast, by Type (2021-2033)

13.2.9.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)

13.2.10. Market Revenue and Volume Forecast, by Patient (2021-2033)

13.2.11. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.2.12. France

13.2.12.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.2.12.2. Market Revenue and Volume Forecast, by Type (2021-2033)

13.2.12.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)

13.2.12.4. Market Revenue and Volume Forecast, by Patient (2021-2033)

13.2.13. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.2.14.2. Market Revenue and Volume Forecast, by Type (2021-2033)

13.2.14.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)

13.2.14.4. Market Revenue and Volume Forecast, by Patient (2021-2033)

13.2.15. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.3. APAC

13.3.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.3.2. Market Revenue and Volume Forecast, by Type (2021-2033)

13.3.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)

13.3.4. Market Revenue and Volume Forecast, by Patient (2021-2033)

13.3.5. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.3.6. India

13.3.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.3.6.2. Market Revenue and Volume Forecast, by Type (2021-2033)

13.3.6.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)

13.3.6.4. Market Revenue and Volume Forecast, by Patient (2021-2033)

13.3.7. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.3.8. China

13.3.8.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.3.8.2. Market Revenue and Volume Forecast, by Type (2021-2033)

13.3.8.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)

13.3.8.4. Market Revenue and Volume Forecast, by Patient (2021-2033)

13.3.9. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.3.10. Japan

13.3.10.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.3.10.2. Market Revenue and Volume Forecast, by Type (2021-2033)

13.3.10.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)

13.3.10.4. Market Revenue and Volume Forecast, by Patient (2021-2033)

13.3.10.5. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.3.11.2. Market Revenue and Volume Forecast, by Type (2021-2033)

13.3.11.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)

13.3.11.4. Market Revenue and Volume Forecast, by Patient (2021-2033)

13.3.11.5. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.4. MEA

13.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.4.2. Market Revenue and Volume Forecast, by Type (2021-2033)

13.4.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)

13.4.4. Market Revenue and Volume Forecast, by Patient (2021-2033)

13.4.5. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.4.6. GCC

13.4.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.4.6.2. Market Revenue and Volume Forecast, by Type (2021-2033)

13.4.6.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)

13.4.6.4. Market Revenue and Volume Forecast, by Patient (2021-2033)

13.4.7. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.4.8. North Africa

13.4.8.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.4.8.2. Market Revenue and Volume Forecast, by Type (2021-2033)

13.4.8.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)

13.4.8.4. Market Revenue and Volume Forecast, by Patient (2021-2033)

13.4.9. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.4.10. South Africa

13.4.10.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.4.10.2. Market Revenue and Volume Forecast, by Type (2021-2033)

13.4.10.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)

13.4.10.4. Market Revenue and Volume Forecast, by Patient (2021-2033)

13.4.10.5. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.4.11.2. Market Revenue and Volume Forecast, by Type (2021-2033)

13.4.11.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)

13.4.11.4. Market Revenue and Volume Forecast, by Patient (2021-2033)

13.4.11.5. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.5. Latin America

13.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.5.2. Market Revenue and Volume Forecast, by Type (2021-2033)

13.5.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)

13.5.4. Market Revenue and Volume Forecast, by Patient (2021-2033)

13.5.5. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.5.6. Brazil

13.5.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.5.6.2. Market Revenue and Volume Forecast, by Type (2021-2033)

13.5.6.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)

13.5.6.4. Market Revenue and Volume Forecast, by Patient (2021-2033)

13.5.7. Market Revenue and Volume Forecast, by End-use (2021-2033)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Volume Forecast, by Product (2021-2033)

13.5.8.2. Market Revenue and Volume Forecast, by Type (2021-2033)

13.5.8.3. Market Revenue and Volume Forecast, by Procedure (2021-2033)

13.5.8.4. Market Revenue and Volume Forecast, by Patient (2021-2033)

13.5.8.5. Market Revenue and Volume Forecast, by End-use (2021-2033)

Chapter 14. Company Profiles

14.1. Smith+Nephew

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Stryker

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Intersect ENT, Inc

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Olympus Corporation

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. SinuSys Corporation

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Johnson & Johnson Services, Inc.

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. TE Connectivity

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. InnAccel Technologies Pvt Ltd

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client